Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study

INTRODUCTION: Ezetimibe/statin combination therapy has been reported to provide additional cardioprotective effects compared to statin monotherapy. The apolipoprotein B/A1 (apoB/A1) ratio is an effective predictor of cardiovascular diseases. The aim of this study was to compare the efficacy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jiwoo, Hwang, You-Cheol, Lee, Woo Je, Won, Jong Chul, Song, Kee-Ho, Park, Cheol-Young, Ahn, Kyu Jeung, Park, Joong-Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136381/
https://www.ncbi.nlm.nih.gov/pubmed/32065359
http://dx.doi.org/10.1007/s13300-020-00778-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136381/
https://www.ncbi.nlm.nih.gov/pubmed/32065359
http://dx.doi.org/10.1007/s13300-020-00778-1

Ejemplares similares